Induction of oxidative stress and glutathione depletion by ABT-737, a novel small molecule inhibitor of Bcl-2, contributes to cytotoxicity in leukemia cells

被引：0
|
作者：
Chandra, Joya [1 ]
Howard, Adrienne [1 ]
Jensen, Kathleen [1 ]
Meyn, Ray [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4336.4336
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4336
引用
收藏
页码：152B / 152B
页数：1
相关论文
共 50 条
  • [1] Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
    Tagscherer, K. E.
    Fassl, A.
    Campos, B.
    Farhadi, M.
    Kraemer, A.
    Boeck, B. C.
    Macher-Goeppinger, S.
    Radlwimmer, B.
    Wiestler, O. D.
    Herold-Mende, C.
    Roth, W.
    ONCOGENE, 2008, 27 (52) : 6646 - 6656
  • [2] Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
    K E Tagscherer
    A Fassl
    B Campos
    M Farhadi
    A Kraemer
    B C Böck
    S Macher-Goeppinger
    B Radlwimmer
    O D Wiestler
    C Herold-Mende
    W Roth
    Oncogene, 2008, 27 : 6646 - 6656
  • [3] BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia
    Moore, Victoria Del Gaizo
    Schlis, Krysta D.
    Sallan, Stephen E.
    Armstrong, Scott A.
    Letai, Anthony
    BLOOD, 2008, 111 (04) : 2300 - 2309
  • [4] ABT-737, a BH3 mimetic, induces glutathione depletion and oxidative stress
    Howard, Adrienne N.
    Bridges, Kathleen A.
    Meyn, Raymond E.
    Chandra, Joya
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 65 (01) : 41 - 54
  • [5] Decreased sensitivity of 17p-deleted chronic lymphocytic leukemia cells to a small molecule BCL-2 antagonist ABT-737
    Kojima, Kensuke
    Duvvuri, Seshagiri
    Ruvolo, Vivian
    Samaniego, Felipe
    Younes, Anas
    Andreeff, Michael
    CANCER, 2012, 118 (04) : 1023 - 1031
  • [6] ABT-737, a BH3 mimetic, induces glutathione depletion and oxidative stress
    Adrienne N. Howard
    Kathleen A. Bridges
    Raymond E. Meyn
    Joya Chandra
    Cancer Chemotherapy and Pharmacology, 2009, 65 : 41 - 54
  • [7] Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer
    Hann, Christine L.
    Daniel, Vincent C.
    Sugar, Elizabeth A.
    Dobromilskaya, Irina
    Murphy, Sara C.
    Cope, Leslie
    Lin, Xue
    Hierman, Jared S.
    Wilburn, Daniel L.
    Watkins, D. Neil
    Rudin, Charles M.
    CANCER RESEARCH, 2008, 68 (07) : 2321 - 2328
  • [8] The Bcl-2/Bcl-XL inhibitor ABT-737 promotes death of retinoblastoma cancer cells
    Allaman-Pillet, Nathalie
    Oberson, Anne
    Munier, Francis
    Schorderet, Daniel F.
    OPHTHALMIC GENETICS, 2013, 34 (1-2) : 1 - 13
  • [9] Radiochemosensitization of primary glioma stem cells by the Bcl-2/Bcl-xL inhibitor ABT-737
    Dheenadayalan, R.
    Firat, E.
    Niedermann, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 118 - 118
  • [10] Induction of Noxa Sensitizes Human Colorectal Cancer Cells Expressing Mcl-1 to the Small-Molecule Bcl-2/Bcl-XL Inhibitor, ABT-737
    Okumura, Kenji
    Huang, Shengbing
    Sinicrope, Frank A.
    CLINICAL CANCER RESEARCH, 2008, 14 (24) : 8132 - 8142
12345